Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Eris Biotech Logo
Eris Biotech Growth Score
80
CB Rank
32306
Heat Score
66
Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors.
Founded
obfuscation
PrivatePre-Seed American Fork, Utah, United States1-10 www.erisbio.com
Biopharma
Biotechnology
Medical
Wellness
Overview

Eris Biotech
Total Funding
obfuscation
Growth Score
80
Heat Score
66

Total Funding
obfuscation
obfuscation
Pre-Seed raised
obfuscation
Growth Score80
-7 pts
in past quarter
Heat Score 66
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Eris Biotech

CB Rank
32306
Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors.
Founded
obfuscation
PrivatePre-Seed American Fork, Utah, United States1-10 www.erisbio.com
Biopharma
Biotechnology
Medical
Wellness

Funding Rounds

Pre-Seed
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Evita Weagel, Rachel Garlick
About the Company
Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors.
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Hypoxia-Activated Prodrugs (HAPs)
Drugs designed to activate in low-oxygen environments within solid tumors to target cancer cells selectively.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Pre Seed Round - Eris Biotech Logo
Pre Seed Round - Eris Biotech
1
obfuscation
Y CombinatorPre-Seed
obfuscation
Pre Seed Round - Eris Biotech Logo
Pre Seed Round - Eris Biotech
1
obfuscation
Y CombinatorPre-Seed
obfuscation
Pre Seed Round - Eris Biotech Logo
Pre Seed Round - Eris Biotech
1
obfuscation
Y CombinatorPre-Seed
obfuscation
Pre Seed Round - Eris Biotech Logo
Pre Seed Round - Eris Biotech
1
obfuscation
Y CombinatorPre-Seed
obfuscation
Pre Seed Round - Eris Biotech Logo
Pre Seed Round - Eris Biotech
1
obfuscation
Y CombinatorPre-Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Pre Seed Round - Eris Biotech Logo
Pre Seed Round - Eris Biotech
1
obfuscation
Y CombinatorPre-Seed
obfuscation
Pre Seed Round - Eris Biotech Logo
Pre Seed Round - Eris Biotech
1
obfuscation
Y CombinatorPre-Seed
obfuscation
Pre Seed Round - Eris Biotech Logo
Pre Seed Round - Eris Biotech
1
obfuscation
Y CombinatorPre-Seed
obfuscation
Pre Seed Round - Eris Biotech Logo
Pre Seed Round - Eris Biotech
1
obfuscation
Y CombinatorPre-Seed
obfuscation
Pre Seed Round - Eris Biotech Logo
Pre Seed Round - Eris Biotech
1
obfuscation
Y CombinatorPre-Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News

News and Press

News•May 6, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 1, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

78
-88.27%
 in past month

Active Website Tech Count

3Eris Biotech is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Klarna.
Sub-Organizations
Frequently Asked Questions

Where is Eris Biotech's headquarters? Eris Biotech is located in American Fork, Utah, United States.Who invested in Eris Biotech? Eris Biotech is funded by Y Combinator.When was the last funding round for Eris Biotech? Eris Biotech closed its last funding round on
obfuscation
from a Pre-Seed round.Who are Eris Biotech's competitors? Alternatives and possible competitors to Eris Biotech may include Telix Pharmaceuticals, HiberCell, and  Apeiron Biologics.How much funding has Eris Biotech raised to date? Eris Biotech has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|